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Abstract— Background: Vitiligo is an acquired depigmenting 
skin disorder that can affect the patients’ quality of life (QOL). 
Objectives: The aim of this study was to evaluate the QOL in 
patients with vitiligo. 
Patients and Methods: This study included 30 patients with 
vitiligo. All the patients filled out  questionnaires Skindex- 29. 
Data were compiled and analyzed statistically. 
Results: Among the 30 vitiligo patients, 73,3 % were women and 
26,7 % were men.  Mean age of patients were 40.53 ± 12. 91 years 
old.  The mean duration of vitiligo was 9.07 ± 7.643 years. The 
mean total Skindex-29 score of the subjects was 24.68 ± 7,72.   
There was significant difference according to age’s group (p = 
0,035) and sex ( p = 0,01) but there is no significant difference 
according to duration of disease’s group  ( p = 0,582 ). 
Conclusions: The study findings showed that vitiligo has a 
significant effect on the patients’ QOL. It seems counselling is 
needed as part of treatment in vitiligo patients. 
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I. INTRODUCTION 
A healthy normal skin is essential for a person's 
physical and mental well being. It is an important 
aspect of their sexual attractiveness, a sense of well 
being and a sense of self confidence. 1  Vitiligo is a 
common condition seen in a dermatology office, 
which has a variety of comorbidities. Worldwide, 
the prevalence of vitiligo ranges from 0.4 to 2.0 %, 
with regions of greater or lesser prevalence.2 Jusuf 
and Meher based on medical records found in 2012 
total vitiligo patients were 18,09% of total visits in 
Cosmetic Division of Outpatient Dermatology and 
Venereology Clinic in H. Adam Malik General 
Hospital Medan , in 2013 were 9,21%, 2014 were 
8,53% and 2015 were 8,45%.3 Most studies 
demonstrate slightly greater prevalence in females.2 
Vitiligo is a common depigmenting skin disorder, 
characterized by acquired, idiopathic, progressive, 
circumscribed hypomelanosis of the skin and hair, 
with total absence of melanocytes microscopically.4  
Vitiligo is an important skin disease having major 
impact on quality of life of patients, many of whom 
feel distressed and stigmatized by their condition.1  
The psychosocial aspects of vitiligo can be 
described by stress as a potential cause or effect of 
the disease, the anxiety or depression of vitiligo 
patients, or the impact of vitiligo on patient quality 
of life.5 In a research conducted by Hamdani and 
Jusuf found pigmentation disorder on face were 
greatly affecting  (54,0%) quality of life in subjects 
at 21 Posyandu in Medan Labuhan.6  
II. METHODOLOGY 
This Patient with confirmed diagnosis of vitiligo 
were included in this study. Our sampling method 
was consecutive sampling. Inclusion criteria were 
diagnosis of vitiligo by a dermatologist and 18 
years or above. Exclusion criteria included 
diagnosis of skin diseases other than vitiligo,  other 
chronic disease or any conditions that might have 
an effect on QOL, and apparent disability. The 
study was conducted in the Dermatology Outpatient 
Clinic of H. Adam Malik General Hospital Medan, 
Indonesia from June 2016 to September 2016. 
Those who were referred to the clinic and met the 
eligibility criteria were recruited. Each subjects 
were explained about the study and asked to answer 
the questions in Skindex-29. This tool inquires 
about how often (never, rarely, sometimes, often, 
all the time) during the previous 4 weeks the patient 
experienced the effect described in each item. 
Seven items address the symptoms domain, 10 
items the emotional domain, and 12 items the 
functioning domain. All responses are transformed 
to a linear scale of 100, varying from 0 (no effect) 
to 100 (effect experienced all the time). Skindex 
scores are reported as three scale scores, 
corresponding to the three domains; a scale score is 
the average of a patient’s responses to items in a 
given domain.7 All data from subjects then were 
analyzed statistically. 
III. RESULTS 
Among the 30 vitiligo patients, 8 patients were men 
and 22 were women. Most patients were 40-49 
years old ( 40%) with mean age was 40.53 ± 12. 91 
years old. 40% of participants had vitiligo for 1-5 
years with mean duration of vitiligo was 9.07 ± 
7.643 years. Most subjects were working as private 
employee and finishing high school (Table 1). 
Based on categorization of total scores, most 
patients were in moderately affected category ( 70%) 
(Table 2). The mean total skindex-29 score of the 
subjects was 24.68 ± 7,72 (Table 3).   There is 
significant difference according to age (p = 0,035) 
and sex ( p = 0,01) but there is no significant 
difference according to duration of disease (p = 
0,582). According to age category, the highest 
mean total score was found in <20 years old group 
( 35,00 ± 0,00) and based on gender, female 
attained higher mean score  ( 27,13 ± 7,55 ) than 



















DISTRIBUTION OF SUBJECTS BASED ON DEMOGRAPHIC AND 




Age (years old) 
n % 
<20 1 3,3 
20- 29  6 20 
30- 39  18 36 
50- 59 years 16 32 
60- 69 years 4 8 
70- 79 years 1 2 
Sex   
Female 22 73,3 
Male 8 26,7 
Education   
Elementary 3 10 
Junior high school 2 6,7 
Senior high school 14 46,7 
University 11 36,7 
Occupation   
Civil Officer 4 13,3 
Enterprenuer 7 23,3 
Private employee 11 36,7 
Unemployment 12 24 
Duration of disease (years)   
1-5 12 40 
6-10 6 20 
11-15 7 23,3 
16-20 4 13,3 
>20 1 3,3 
 
TABEL 2 
DISTRIBUTION OF SUBJECT BASED ON TOTAL SKINDEX-29 SCORE 
CATEGORIZATION 
 
Total Score Category n % 
<5 Very little 0 0 
6-17  Mild 9 30 
18-36  Moderate 21 70 
≥37 Severe 0 0 
 
 Distribution quality of life scores in this study 
showed 38 (76%) subjects had a very high quality 
of life and 12 (24%) subjects had a high quality of 
life and we didn’t find a moderate or low quality of 
life score in all subjects (Table. 2), furthermore 
based on the characteristics of the skin tag lesions 
we also didn’t find a significant difference in the 











TOTAL SCORE OF SKINDEX-29 
 





30 16.70 35.00 24.6800 7.7224  
 
TABEL 4 
DISTRIBUTION CATEGORY OF QUALITY OF LIFE  
 
Variable Mean of total 
score ± SD 
P 
Sex   
Male  17,95 ± 2,31 0,001 
Female  27,13 ± 7,55  
Age (years old)   
<20 35,00 ± 0,00  
20-29 31,95±7,47  
30-39 21,70±0,00  
40-49 20,84±5,18 0,035 
50-59 16,70±9,15  




1-5 23,64± 7,69  
6-10 23,08± 6,17  
11-15 25,97± 8,69 0,582 
16-20 28,68±8,83  
≥20 16,70±0,00  
 
IV. DISCUSSION 
Vitiligo considerably influences the psychological 
well-being of patients. Disease-induced 
disfigurement can cause patients to experience a 
high level of stigmatization, which can lead to 
psychosocial stresses and negative impacts on 
quality of life (QOL).8 Vitiligo is a multi-factorial 
pigmentary skin disorder. Recently, the importance 
of emotional and psychological issues is proposed 
in incidence, progression, relapse and remission of 
vitiligo. There are limited studies conducted in 
developing countries, which assess life quality of 
patients with vitiligo.9 
Kim et al in Korea conducted a study 
regarding the impact of vitiligo in patient’ life with 
similar tool. This study was involving one hundred 
and thirty-three vitiligo patients and 112 patients 
with mild skin disorders. They found the symptom 
scale of Skindex-29 was significantly lower in 
vitiligo patients than in controls, but the function 
scale and the emotion scale were significantly 
higher in the vitiligo group than in controls. 
However, the difference in function scales between 
groups was significant in female patients, but not in 
male patients. Several clinical profiles, such as 
duration of disease, severity scores and previous 
history of treatments, showed close correlations 
with the function scale. Family history of vitiligo, 
Köebner phenomenon, patients’ perspectives on 
disease prognosis, and discordance of the severity 
scores between physicians and patients also 
influenced the Skindex-29 subscales differently. In 
their conclusion, the study suggests that patients 
with vitiligo were highly affected in the functional 
and emotional aspects of QOL, with some sex 
differences and perhaps various clinical features 
may play an important role in the QOL of vitiligo 
patients.8 
Study by Ghaderi and Saadatjo in Iran 
involved 70 patients with vitiligo. All the patients 
filled out two questionnaires: Short Form 36 (SF-36) 
and Dermatology Life Quality Index (DLQI).  The 
mean score of patients with vitiligo on DLQI scale 
was 8.40 ± 5.76 (range, 0-23).Although males 
scores on SF-36 scale was higher than females, the 
difference was not statistically significant. With 
regard to age, the mean total score of SF-36 
indicated insignificant differences among age 
groups. Their findings showed that vitiligo has a 
significant effect on the patients’ QOL.10 
Hedayat et al conducted  a study on 25 
patients as a pilot and another 173 patients as the 
main study group, in Razi Hospital, Tehran, Iran, 
2013–2014. Persian version of Vitiligo Quality of 
Life index (VitiQoL) was developed with 
backward-forward method. The Vitiligo Area and 
Score Index (VASI), VitiQoL, and their 
relationship, demographic and clinical characteristic 
of patients were measured.The Mean and standard 
deviation of the VitiQoL score was 30.5 ± 14.5 
(range 0–60 in Persian version). They found a 
significant relationship between VASI score and 
VitiQoL (p = 0.015, r = 0.187. Based on behavior 
factor, female patients had poorer quality of life (p 
= 0.02). Concomitant psychiatric problems, e.g. 
anxiety and depression, were not associated with 
QOL; however, they were near to being meaning (p 
=0.06, r =0.14).9 
A study by Karia et al tried to determine the 
psychiatric morbidity and the QOL in patients 
suffering from vitiligo and to determine the factors 
related with psychiatric morbidity and those 
affecting the QOL in vitiligo patients. 50 patients of 
age range 18 – 65 years with disease duration of 1-
26 years attending the vitiligo clinic in dermatology 
outpatient department of a tertiary care hospital 
were included and 50 persons with no 
dermatological or diagnosed psychiatric illness 
accompanying them served as control group. They 
found 30% patients in vitiligo group suffered from 
psychiatric disorder, depression was present in 20% 
of patients and 8% had anxiety disorder. Thus it 
was found that vitiligo patients had more 
psychiatric comorbidities as compared to control 
group and it had bearing on their quality of life 
too.11 
Vitiligo is an acquired depigmentary skin 
disorder characterized by white macules on the skin 
associated with social stigma. Vitiligo has major 
impact on the quality of life due its high cosmetic 
value, chronic nature of disease and long term 
ineffective treatments. Vitiligo patients suffer from 
low self-esteem and poor body image that affects 
their emotional and psychological well-being. To 
investigate quality of life of v itiligo patients, 
psychological impact of unpredictable course of 
disease and long term treatment among South 
Indian population Mateen et al conducted a study  
involving a total of 155 vitiligo patients who were 
undertaking treatment in dermatology clinic at the 
Central Research Institute of Unani Medicine. They 
found patients with vitiligo averaged at about 27.4% 
of maximum psychological impairment as 
measured by the Dermatology Quality of Life Index 
(DQLI)  summary score. Disability in patients was 
highest in treatment category with 54.6% of 
impairment followed by symptoms and feelings 
(41.83%). Dark skin, unmarried, slow responders to 
the treatment and those having chronicity more than 
5 years showed worse quality of life and had 70%, 
61%, 62%and 76.5% of impairment in the treatment 
front of DLQI respectively when compared to light 
skin (50%), married (52.5%), rapid responders 
(26%) and chronicity less than 5 years (52%). There 
was no significant difference in the quality of life 
between male and female Vitiligo patients. Their 
results show that vitiligo patients suffer in all 
aspects of life especially in treatment aspect of 
DLQI and psychological impairment strongly 
affects the social well-being of vitiligo patients.12 
A study group comprised of 54 subjects with 
vitiligo, 57 with psoriasis and 57 unaffected 
controls with all subjects were examined and 
interviewed using the DLQI and Emotional State 
questionnaires. They found total mean DLQI score 
in vitiligo was 4.7, compared with 0.6 in healthy 
controls (p < 0.001) and 13.1 in psoriasis (p < 
0.001). In vitiligo, females experienced a greater 
impact on feelings and men experienced a greater 
impact on relationships. Lower quality of life in 
vitiligo was associated with active stage of the 
disease, extension of pigment loss, depigmentation 
on the hands, and  earlier onset of disease. The 
results demonstrate that vitiligo has less impact on 
quality of life than psoriasis. This case-control 
study of fair-skinned subjects demonstrates the low 
level of disease-related impairment in QOL in 
vitiligo compared with the severe impairment in 
QOL in psoriasis. 13 
In our study we found  the mean total 
skindex-29 score of the subjects was 24.68 ± 7,72. 
According to Nijsten categorization, it fell on 
moderate category.14 There is significant difference 
according to age’s group (p = 0,035) and sex (p = 
0,01) but there is no significant difference 
according to duration of disease (p = 0,582). This 
might be because women and younger people are 
more concern in appearance than men and older 
ones.  
V. CONCLUSIONS 
Vitiligo can affect patient’s quality of life because 
cosmetically disturbing. Counselling may be 
needed as part of treatment to improve subjects and 
their families’ attitude toward this disease. 
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